IXICO – “successfully grown its pipeline of new opportunities”, so why are the shares further lower?...
Having been above 100p as recently as April, shares in biopharmaceutical data analytics company IXICO (IXI) are currently further lower at 72p despite a trading update including that “the company has successfully grown its pipeline of new opportunities”. So what’s going on?...

